Home » Stocks » Timber Pharmaceuticals

Timber Pharmaceuticals, Inc. (TMBR)

Stock Price: $1.52 USD 0.39 (34.51%)
Updated Oct 21, 2020 4:00 PM EDT - Market closed
Pre-market: $1.51 -0.01 (-0.66%) Oct 22, 5:47 AM

Stock Price Chart

Key Info

Market Cap 18.29M
Revenue (ttm) 351,553
Net Income (ttm) -21.00M
Shares Out 12.03M
EPS (ttm) -1.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 21, 2020
Last Price $1.52
Previous Close $1.13
Change ($) 0.39
Change (%) 34.51%
Day's Open 1.13
Day's Range 1.10 - 1.63
Day's Volume 6,875,835
52-Week Range 0.87 - 12.60

More Stats

Market Cap 18.29M
Enterprise Value 5.35M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 12.03M
Float 6.40M
EPS (basic) n/a
EPS (diluted) -1.75
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 946,660
Short Ratio 1.76
Short % of Float 14.79%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 52.02
PB Ratio n/a
Revenue 351,553
Operating Income n/a
Net Income -21.00M
Free Cash Flow n/a
Net Cash 12.94M
Net Cash / Share 1.08
Gross Margin -869.86%
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $1.52
Target: 12.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth--21.92%-27%56.25%--
Gross Profit--0.03-0.18-0.42-0.17-
Operating Income-9.69-16.51-16.88-18.43-15.16-7.77
Net Income-9.69-17.26-16.64-18.41-15.60-7.81
Shares Outstanding1.080.640.
Earnings Per Share-9.00-26.76-57.00-156.01-267.01-240.01
Operating Cash Flow-10.11-14.99-15.59-15.75-12.61-6.00
Capital Expenditures-0.03-0.04-0.04-0.05-0.04-0.23
Free Cash Flow-10.14-15.04-15.63-15.79-12.65-6.23
Cash & Equivalents-3.077.586.504.04-
Net Cash / Debt-3.077.586.504.04-
Book Value-1.305.072.972.05-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Timber Pharmaceuticals, Inc.
Country United States
Employees 6
CEO John Koconis

Stock Information

Ticker Symbol TMBR
Stock Exchange NYSE American
Sector Healthcare
Industry Biotechnology
Unique Identifier NYSEAMERICAN: TMBR


Timber Pharmaceuticals LLC, a clinical-stage medical dermatology company, focuses on the development and commercialization of pharmaceuticals for treatment of orphan dermatologic diseases. The company was founded in 2019 and is based in Woodcliff Lake, New Jersey.